No Data
No Data
Entero Therapeutics | 10-K/A: Annual report (Amendment)
Why Sangamo Therapeutics Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket
Trending Stocks Today | American Tower Corp Dips 3.58% Post-Market
Entero Therapeutics | 10-K: FY2024 Annual Report
Entero Therapeutics Announces Signing of Rescission Agreement With ImmunogenX, LLC
12 Health Care Stocks Moving In Monday's After-Market Session